Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shin‑Ichirou Mori"'
Autor:
KUNIAKI ARIDOME1,2 aridome-k3@hotmail.co.jp, SHIN-ICHIROU MORI1, KENJI BABA1, MASAYUKI YANAGI1, MASAHIRO HAMANOUE3, FUTOSHI MIYAZONO4, KOUKI TOKUDA5, HIROSHI IMAMURA6, YOSHITO OGURA7, KOUICHI KANEKO8, FUMIO KIJIMA2, KOUSEI MAEMURA1, SUMIYA ISHIGAMI1, SHOJI NATSUGOE1
Publikováno v:
Molecular & Clinical Oncology. Mar2016, Vol. 4 Issue 3, p393-398. 6p.
Autor:
Hiroshi Imamura, Kousei Maemura, Yoshito Ogura, Shin‑Ichirou Mori, Kuniaki Aridome, Sumiya Ishigami, Shoji Natsugoe, Kouichi Kaneko, Futoshi Miyazono, Fumio Kijima, Masayuki Yanagi, Kouki Tokuda, Masahiro Hamanoue, Kenji Baba
Publikováno v:
Molecular and Clinical Oncology. 4:393-398
The present study aimed to study the efficacy of aprepitant in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC) for colorectal cancer (CRC), and comprised a multicenter,
Autor:
Yuichi, Nakamura, Hisashi, Sakamaki, Harumi, Mukai, Hiroshi, Kojima, Junji, Tomiyama, Shin-ichirou, Mori, Kiyoshi, Hiruma, Norihiko, Nakamura, Shigeo, Toyota, Hiroyuki, Hamaguchi, Kazuo, Dans, Kinuko, Mitani, Kenji, Saito
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 45(7)
A feasibility study on high-dose therapy with autologous peripheral blood stem cell transplantation (HDT/PBSCT) was performed in Japanese patients with multiple myeloma (MM). Twenty evaluable patients younger than 65 years old with stage II/III MM we